Rituximab Does Not Prevent Graft Loss in Renal Transplant Recipients With Chronic Antibody Mediated Rejection With Significant Renal Impairment and Nephrotic Range Proteinuria.

被引：0
|
作者：
Anwar, S. [1 ]
Delos Santos, R. [1 ]
Horwedel, T. [1 ]
Brennan, D. [1 ]
Klein, C. [1 ]
机构：
[1] Washington Univ, Sch Med, Div Renal, St Louis, MO 63110 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2014年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
A273
引用
收藏
页码：477 / 477
页数：1
相关论文
共 50 条
  • [21] ADDITION OF RITUXIMAB TO INDUCTION THERAPY DECREASES RISK OF ANTIBODY-MEDIATED REJECTION AND GRAFT LOSS IN RENAL TRANSPLANT RECIPIENTS WITH POSITIVE FLOW CROSSMATCH AND DONOR SPECIFIC ANTIBODIES
    Anwar, Siddiq
    Horwedel, Timothy
    Ashraf, Muhammad
    Khalid, Syed
    Brennan, Daniel
    Klein, Christina
    TRANSPLANT INTERNATIONAL, 2013, 26 : 79 - 79
  • [22] Excellent Outcomes in Renal Transplant Recipients Switching to Rapamycin Due to Chronic Allograft Dysfunction with Low Proteinuria.
    Gutierrez, Maria J.
    Gonzalez, Esther
    Andres, Amado
    Morales, Jose M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 202 - 202
  • [23] Significant Association of Non Traditional Anti-Hla Antibodies with Antibody Mediated Rejection in Renal Transplant Recipients
    Lim, E. K.
    Anantharaman, V.
    TRANSPLANTATION, 2012, 94 (10) : 864 - 864
  • [24] The Role of Bortezomib in Pediatric Renal Transplant Recipients With Antibody Mediated Rejection.
    Nayak, A.
    Tsai, E.
    Ettenger, R.
    TRANSPLANTATION, 2014, 98 : 499 - 499
  • [25] Tocilizumab Stabilizes Renal Function in Kidney Transplant Recipients with Chronic Active Antibody Mediated Rejection (CAAMR).
    Patel, S.
    Mohan, S.
    Fernandez, H.
    Batal, I.
    Ratner, L.
    Crew, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 326 - 326
  • [26] Investigating the Role of BAFF and Its Receptors in Renal Transplant Recipients with Chronic Antibody-Mediated Rejection
    Afzali, Shima
    Salehi, Saeedeh
    Shahi, Abbas
    Esmaeili, Marzie
    Bonab, Samad Farashi
    Peykari, Azin
    Bagherpour, Farzaneh
    Ansaripour, Bita
    Soleimanian, Tayebeh
    Pour-Reza-Gholi, Fatemeh
    Amirzargar, Aliakbar
    JOURNAL OF IMMUNOLOGY RESEARCH, 2021, 2021
  • [27] Treatment of chronic humoral rejection in pediatric renal transplant recipients with IVIG and rituximab.
    Billing, Heiko
    Rieger, Susanne
    Suesal, Caner
    Ruediger, Waldherr
    Toenshoff, Burkhard
    PEDIATRIC TRANSPLANTATION, 2007, 11 : 47 - 47
  • [28] Donor Specificity but Not Broadness of Sensitization Is Associated With Antibody-Mediated Rejection and Graft Loss in Renal Allograft Recipients
    Wehmeier, C.
    Honger, G.
    Cun, H.
    Amico, P.
    Hirt-Minkowski, P.
    Georgalis, A.
    Hopfer, H.
    Dickenmann, M.
    Steiger, J.
    Schaub, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (08) : 2092 - 2102
  • [29] A systematic review of the use of rituximab for the treatment of antibody-mediated renal transplant rejection
    Macklin, Philip S.
    Morris, Peter J.
    Knight, Simon R.
    TRANSPLANTATION REVIEWS, 2017, 31 (02) : 87 - 95
  • [30] Outcome of Renal Transplant Recipients With Chronic Antibody Mediated Rejection - The Role of Intravenous Immunoglobulin and Plasmapheresis Treatment.
    Ma, M.
    Lam, M.
    Choy, C.
    Chan, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 511 - 511
12345